Sudhir Agrawal, D. Phil

2015

In 2015, Sudhir Agrawal, D. Phil earned a total compensation of $923.8K as President of Research at Idera Pharmaceuticals, a 70% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$302,577
Salary$588,100
Other$33,172
Total$923,849

Phil received $588.1K in salary, accounting for 64% of the total pay in 2015.

Phil also received $302.6K in non-equity incentive plan and $33.2K in other compensation.

Rankings

In 2015, Sudhir Agrawal, D. Phil's compensation ranked 8,326th out of 13,638 executives tracked by ExecPay. In other words, Phil earned more than 38.9% of executives.

ClassificationRankingPercentile
All
8,326
out of 13,638
39th
Division
Manufacturing
3,169
out of 5,190
39th
Major group
Chemicals And Allied Products
1,152
out of 1,854
38th
Industry group
Drugs
929
out of 1,528
39th
Industry
Biological Products, Except Diagnostic Substances
159
out of 254
37th
Source: SEC filing on April 28, 2017.

Phil's colleagues

We found four more compensation records of executives who worked with Sudhir Agrawal, D. Phil at Idera Pharmaceuticals in 2015.

2015

R Fletcher

Idera Pharmaceuticals

Senior Vice President, Business Development and Strategy

2015

Mark Casey

Idera Pharmaceuticals

General Counsel

2015

Vincent Milano

Idera Pharmaceuticals

Chief Executive Officer

2015

Louis Arcudi

Idera Pharmaceuticals

Chief Financial Officer

You may also like